MelanomaArchives
Combining multi-omics analysis with machine learning to uncover novel molecular subtypes, prognostic markers, and insights into immunotherapy for melanoma
Melanoma 9 min.
Melanoma, originating from melanocytes in the skin’s outer layer, is an aggressive form of cancer. It is known for its rapid spread and resistance to therapy, leading to a high fatality rate [1]. While the five-year survival rate for early-stage melanoma is nearly 100%, this figure significantly...
Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma study
Melanoma 5 min.
Malignant melanoma (MM) arises from the pigment cells of the skin and is a rare form of cutaneous cancer. Although the annual incidence of melanoma in Japan has been reported to be 1-2 patients/100,000 [1, 2], MM-related mortalities are close to half the cutaneous cancer deaths because of its aggressiveness...
Prognostic value and immune infiltration of a tumor microenvironment-related PTPN6 in metastatic melanoma
Melanoma 8 min.
Despite its low incidence, melanoma is one of the most aggressive skin cancers, accounting for nearly 90% of all skin malignant tumor deaths [1]. Early primary melanoma patients can achieve a good prognosis after surgical resection [2]. However, advanced metastatic melanoma presents a significant challenge...
Malignant melanoma in Portuguese adult population: a scoping review of the real-world evidence
Melanoma 3 min.
Malignant melanoma arises from the uncontrolled proliferation of malignant melanocytes and accounts for 1.7% of all cancer diagnoses [1,2,3]. This malignancy is a life-threatening form of skin cancer and it is known by its aggressiveness [1, 3,4,5]. There are four main types as cutaneous melanoma, acral...
